跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Velcade - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Velcade
Approved
STANDARD
Velcade
Pierre Fabre Medicament Production
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
05d9cbe97d3c6d21
Company
Pierre Fabre Medicament Production
Type
Standard
Approval Details
Approval Id
05d9cbe97d3c6d21
Drug Approval Philippines Name
Velcade
Product Name
Velcade
Registration Number
DR-XY39166
Brand Name
Velcade
Generic Name
Bortezomib
Dosage Form
Powder For Injection (IV/SC)
Dosage Strength
3.5 mg/vial
Manufacturer
Pierre Fabre Medicament Production
Importer
Johnson & Johnson (Philippines), Inc.
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/pierre-fabre-medicament-production
Issuance Date
11 June 2021
Expiry Date
11 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
05d9cbe97d3c6d21
Type
Standard
Back to Philippines FDA Approvals